NurExone Biologic Inc. (TSXV:NRX)
0.4600
-0.0300 (-6.12%)
Nov 20, 2026, 4:00 PM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 44.34 million as of November 20, 2026. It is the 33,099th most valuable company in the world and the 905th biggest in Canada. Its market cap has decreased by 30.63% in one year.
Market Cap
44.34M
Enterprise Value
42.99M
Revenue
n/a
Global Rank
Country Rank
#905 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 44.34M, an increase of 32.43%. That is a compound annual growth rate of 6.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 44.34M | -25.91% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 68.74M |
| Sharp Therapeutics | 43.26M |
| Thiogenesis Therapeutics | 41.29M |
| BriaCell Therapeutics | 40.65M |
| Microbix Biosystems | 40.41M |
| MedMira | 38.60M |
| Sernova Biotherapeutics | 33.99M |
| Sona Nanotech | 31.93M |